Eleftherios Papalanis
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy.
Journal: Frontiers in oncology
Published: March 05, 2026
Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.
Journal: International journal of molecular sciences
Published: December 29, 2025
Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.
Journal: International journal of biological macromolecules
Published: November 13, 2025
Author Correction: Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer.
Journal: Scientific reports
Published: July 29, 2025
Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68.
Journal: ACS pharmacology & translational science
Published: April 30, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.
Journal: International journal of molecular sciences
Published: March 29, 2025
In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup.
Journal: Clinical and translational radiation oncology
Published: March 04, 2025
An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo.
Journal: Translational oncology
Published: January 30, 2025
Designed Ankyrin Repeat Protein-Mediated Peptide Nucleic Acid-Based Pretargeting: A Proof-of-Principle Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 16, 2025
Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules.
Journal: ACS pharmacology & translational science
Published: September 09, 2024
Last Updated: 09/26/2026